logo-large
  • Browse Categories

Publications by authors named "Matthew Appleby"

Claim this Profile
M
Minimal clinically important differences for treatment of hallucinations in Parkinson's disease and dementia with Lewy bodies.
Suzanne Reeves, Josef Mahdi, Matthew Appleby, Olga Zubko, Teresa Lee

Psychol Med· March 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease.
Thomas Payne, Matthew Appleby, Ellen Buckley, Linda M A van Gelder, Benjamin H Mullish

Mov Disord· August 2023


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson's disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' study.
Thomas Payne, Matilde Sassani, Ellen Buckley, Sarah Moll, Adriana Anton, Matthew Appleby

BMJ Open· August 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: